In response to chemotherapy, Ruffell and colleagues demonstrated that macrophage-derived IL-10 limits effective cytotoxic CD8+ T cells via suppression of IL-12 expression from intratumoral dendritic cells in the MMTV-PyMT model of mammary carcinoma [145]. The gene discussed is CD8A; the disease is breast carcinoma.